Jimmy Zhang
Biotech BD executive, mentor, and adjunct professor
San Francisco Bay Area
Summary
Seasoned business development and deal executive with deep experience across large pharmas and startups. cbpfcn+2
Founder and senior leader in gene and cell therapy entrepreneurship, having founded and led companies and raised significant venture and strategic funding. cbpfcn+1
Educator and mentor: teaches master's students, mentors entrepreneurs, and runs BD-focused workshops and events. shine-consultant+2
Contributor to academic and educational materials on China biotechnology and corporate strategy, including co-authoring the Harvard Business School BeiGene case and related teaching materials. hbs+1
International bridge-builder in biotech and venture investing, advising and working across the US, China, and Korea. cbpfcn+1
Work
Education
Writing
Book chapter: "The Emergence and Transformation of China in Biotechnology" (contributor)
January 1, 2020Authored a chapter on China's biotechnology emergence and transformation (chapter contribution noted in profile bios and speaker summaries).
BeiGene (Teaching Note)
January 1, 2018Harvard Business School teaching note accompanying the BeiGene case, used for classroom instruction and discussion of strategy and regulatory context.
BeiGene Supplemental PowerPoint
January 1, 2018PowerPoint supplement for the BeiGene HBS case, providing slides to be used alongside the case and teaching note.
BeiGene (HBR Case)
January 1, 2017Harvard Business School case study (co-authored) analyzing BeiGene's strategy exploiting regulatory timing differences in China and the implications of 2017 regulatory reforms.